69 related articles for article (PubMed ID: 38488487)
21. Liver resection versus microwave ablation for hepatocellular carcinoma in ideal candidates for ablation per Barcelona Clinic Liver Cancer staging: a propensity score matching and inverse probability of treatment weighting analysis.
Tong Y; Cai R; Li JX; Chang DH; Wang LZ; Cai WW; Xiao YD
Aliment Pharmacol Ther; 2022 Dec; 56(11-12):1602-1614. PubMed ID: 36285593
[TBL] [Abstract][Full Text] [Related]
22. Surgery versus Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF Trial).
Takayama T; Hasegawa K; Izumi N; Kudo M; Shimada M; Yamanaka N; Inomata M; Kaneko S; Nakayama H; Kawaguchi Y; Kashiwabara K; Tateishi R; Shiina S; Koike K; Matsuyama Y; Omata M; Makuuchi M; Kokudo N
Liver Cancer; 2022 Jun; 11(3):209-218. PubMed ID: 35949295
[TBL] [Abstract][Full Text] [Related]
23. Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers.
Renzulli M; Brandi N; Pecorelli A; Pastore LV; Granito A; Martinese G; Tovoli F; Simonetti M; Dajti E; Colecchia A; Golfieri R
Diagnostics (Basel); 2022 Mar; 12(4):. PubMed ID: 35453882
[TBL] [Abstract][Full Text] [Related]
24. Microwave ablation versus laparoscopic resection as first-line therapy for solitary 3-5-cm HCC.
Wang Z; Liu M; Zhang DZ; Wu SS; Hong ZX; He GB; Yang H; Xiang BD; Li X; Jiang TA; Li K; Tang Z; Huang F; Lu M; Chen JA; Lin YC; Lu X; Wu YQ; Zhang XW; Zhang YF; Cheng C; Ye HL; Wang LT; Zhong HG; Zhong JH; Wang L; Chen M; Liang FF; Chen Y; Xu YS; Yu XL; Cheng ZG; Liu FY; Han ZY; Tang WZ; Yu J; Liang P
Hepatology; 2022 Jul; 76(1):66-77. PubMed ID: 35007334
[TBL] [Abstract][Full Text] [Related]
25. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.
Reig M; Forner A; Rimola J; Ferrer-Fàbrega J; Burrel M; Garcia-Criado Á; Kelley RK; Galle PR; Mazzaferro V; Salem R; Sangro B; Singal AG; Vogel A; Fuster J; Ayuso C; Bruix J
J Hepatol; 2022 Mar; 76(3):681-693. PubMed ID: 34801630
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
[TBL] [Abstract][Full Text] [Related]
27. Surgical treatment of hepatocellular carcinoma.
Sugawara Y; Hibi T
Biosci Trends; 2021 Jul; 15(3):138-141. PubMed ID: 33746184
[TBL] [Abstract][Full Text] [Related]
28. Laparoscopic Liver Resection versus Percutaneous Radiofrequency Ablation for Small Single Nodular Hepatocellular Carcinoma: Comparison of Treatment Outcomes.
Lee DH; Kim JW; Lee JM; Kim JM; Lee MW; Rhim H; Hur YH; Suh KS
Liver Cancer; 2021 Feb; 10(1):25-37. PubMed ID: 33708637
[TBL] [Abstract][Full Text] [Related]
29. Central Hepatectomy Versus Major Hepatectomy for Centrally Located Hepatocellular Carcinoma: A Propensity Score Matching Study.
Orimo T; Kamiyama T; Kakisaka T; Shimada S; Nagatsu A; Asahi Y; Sakamoto Y; Kamachi H; Taketomi A
Ann Surg Oncol; 2021 Oct; 28(11):6769-6779. PubMed ID: 33646429
[TBL] [Abstract][Full Text] [Related]
30. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
31. Comparison of radiofrequency ablation and surgical resection for hepatocellular carcinoma conforming to the Milan criteria: a meta-analysis.
Wang Q; Tang M; Zhang S
ANZ J Surg; 2021 Jul; 91(7-8):E432-E438. PubMed ID: 33404115
[TBL] [Abstract][Full Text] [Related]
32. Microwave ablation shows similar survival outcomes compared with surgical resection for hepatocellular carcinoma between 3 and 5 cm.
Zheng H; Xu C; Wang X; Li J; Zhao X; Qi J; Feng Y; Zhu Q
Int J Hyperthermia; 2020 Nov; 37(1):1345-1353. PubMed ID: 33289415
[TBL] [Abstract][Full Text] [Related]
33. New advances in the diagnosis and management of hepatocellular carcinoma.
Yang JD; Heimbach JK
BMJ; 2020 Oct; 371():m3544. PubMed ID: 33106289
[TBL] [Abstract][Full Text] [Related]
34. Liver Resection Versus Local Ablation Therapies for Hepatocellular Carcinoma Within the Milan Criteria: A Systematic Review and Meta-analysis.
Shin SW; Ahn KS; Kim SW; Kim TS; Kim YH; Kang KJ
Ann Surg; 2021 Apr; 273(4):656-666. PubMed ID: 33074898
[TBL] [Abstract][Full Text] [Related]
35. AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway.
Chen T; Dai X; Dai J; Ding C; Zhang Z; Lin Z; Hu J; Lu M; Wang Z; Qi Y; Zhang L; Pan R; Zhao Z; Lu L; Liao W; Lu X
Cell Death Dis; 2020 Oct; 11(10):822. PubMed ID: 33009373
[TBL] [Abstract][Full Text] [Related]
36. Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring.
Sun N; Lee YT; Zhang RY; Kao R; Teng PC; Yang Y; Yang P; Wang JJ; Smalley M; Chen PJ; Kim M; Chou SJ; Bao L; Wang J; Zhang X; Qi D; Palomique J; Nissen N; Han SB; Sadeghi S; Finn RS; Saab S; Busuttil RW; Markovic D; Elashoff D; Yu HH; Li H; Heaney AP; Posadas E; You S; Yang JD; Pei R; Agopian VG; Tseng HR; Zhu Y
Nat Commun; 2020 Sep; 11(1):4489. PubMed ID: 32895384
[TBL] [Abstract][Full Text] [Related]
37. The effect of tumor location on long-term results of microwave ablation for early-stage hepatocellular carcinoma.
Dou JP; Han ZY; Cheng ZG; Liu FY; Yu XL; Yu J; Liang P
Abdom Radiol (NY); 2020 Nov; 45(11):3923-3933. PubMed ID: 32424609
[TBL] [Abstract][Full Text] [Related]
38. Fully laparoscopic thermo-ablation of liver malignancies with or without liver resection: tumor location is an independent local recurrence risk factor.
Ledoux G; Amroun K; Rhaiem R; Cagniet A; Aghaei A; Bouche O; Hoeffel C; Sommacale D; Piardi T; Kianmanesh R
Surg Endosc; 2021 Feb; 35(2):845-853. PubMed ID: 32076859
[TBL] [Abstract][Full Text] [Related]
39. Radiofrequency ablation vs. surgical resection for resectable hepatocellular carcinoma: A systematic review and meta-analysis.
Li JK; Liu XH; Cui H; Xie XH
Mol Clin Oncol; 2020 Jan; 12(1):15-22. PubMed ID: 31814972
[TBL] [Abstract][Full Text] [Related]
40. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
Zhou M; Wang H; Zeng X; Yin P; Zhu J; Chen W; Li X; Wang L; Wang L; Liu Y; Liu J; Zhang M; Qi J; Yu S; Afshin A; Gakidou E; Glenn S; Krish VS; Miller-Petrie MK; Mountjoy-Venning WC; Mullany EC; Redford SB; Liu H; Naghavi M; Hay SI; Wang L; Murray CJL; Liang X
Lancet; 2019 Sep; 394(10204):1145-1158. PubMed ID: 31248666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
